期刊
NEUROPSYCHOPHARMACOLOGY
卷 38, 期 1, 页码 124-137出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2012.73
关键词
depression; epigenetics; chromatin; acetylation; methylation; psychiatry
资金
- NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER
- NIMH NIH HHS [P50 MH096890] Funding Source: Medline
Major depressive disorder is a chronic, remitting syndrome involving widely distributed circuits in the brain. Stable alterations in gene expression that contribute to structural and functional changes in multiple brain regions are implicated in the heterogeneity and pathogenesis of the illness. Epigenetic events that alter chromatin structure to regulate programs of gene expression have been associated with depression-related behavior, antidepressant action, and resistance to depression or 'resilience' in animal models, with increasing evidence for similar mechanisms occurring in postmortem brains of depressed humans. In this review, we discuss recent advances in our understanding of epigenetic contributions to depression, in particular the role of histone acetylation and methylation, which are revealing novel mechanistic insight into the syndrome that may aid in the development of novel targets for depression treatment. Neuropsychopharmacology Reviews (2013) 38, 124-137; doi:10.1038/npp.2012.73; published online 13 June 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据